Document is current
Any future updates will be listed below
-
Authors
Vestring, Stefan https://orcid.org/0000-0001-9150-8712
Veleanu, Maxime https://orcid.org/0000-0001-6760-3488
Perez, Marina Conde
Schuberth, Louise E. https://orcid.org/0009-0005-1338-7261
Bronnec, Martin
Li, Anna
Würz, Lovis M.
Erdogdu, Fatih
Stocker, Julia
Moos, Johanna
Weigel, David
Theiß, Alice
Wendler, Elisabeth
Borger, Lotta M. https://orcid.org/0009-0006-0747-4163
Voita, Sabine
Heynicke, Franziska https://orcid.org/0000-0003-4089-1103
Brandl, Jakob https://orcid.org/0009-0005-8212-1758
Hummel, Fabian https://orcid.org/0009-0008-9077-9762
Vivet, Clotilde
Jocher, Dorothea https://orcid.org/0009-0005-7175-2079
Loewe, Pauline
Barmann, Simon
Smoltczyk, Lea
Zimmermann, Stella
Prabhakaran, Prejwal https://orcid.org/0009-0007-3845-535X
Lokaj, Granita
Sarrazin, David H. https://orcid.org/0000-0003-1326-3232
Suarez, Guillermo https://orcid.org/0009-0005-6219-0174
Bernhardt, Judith
du Vinage, Catherine
Grießbach, Elisa
Lais, Julia
Gensch, Nicole https://orcid.org/0000-0003-4578-6409
Wojtas, Magdalena
Knafo, Shira https://orcid.org/0000-0002-4478-7584
Wendel, Jule
Warneke, Jan
Grohe, Jean-Paul
Günther, Stefan https://orcid.org/0000-0003-3744-189X
Moumbock, Aurélien F. A. https://orcid.org/0000-0002-6034-2016
Domschke, Katharina https://orcid.org/0000-0002-2550-9132
Serchov, Tsvetan https://orcid.org/0000-0002-2234-2875
Bischofberger, Josef https://orcid.org/0000-0002-4006-1663
Normann, Claus https://orcid.org/0000-0001-5693-8936
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (SE266/2-1)
Bundesministerium für Bildung, Wissenschaft, Forschung und Technologie (GO-Bio INNOVADE 16LW0223)
Bundesministerium für Bildung, Wissenschaft, Forschung und Technologie (GO-Bio INNOVADE 16LW0455)
Fondation pour la Recherche Médicale (AJE201912009450)
Université de Strasbourg (USIAS 2020-035)
Centre National de la Recherche Scientifique (CNRS UPR3212)
- License Information
-
More Information
Article History
Received: 26 July 2024
Accepted: 14 November 2025
First Online: 26 November 2025
Competing interests
: C.N., S.Ve., and K.D. received lecture fees and advisory board honoraria from Johnson & Johnson, the manufacturer of Esketamine. C.N. received research support as a principal investigator in clinical trials sponsored by Johnson & Johnson. C.N. received honoraria as a member of a DMC board by Novartis. C.N. and S.Ve. are named coinventors on a patent filed by the University of Freiburg for the use of GluN2D inhibitors in the treatment of depression (EP 22153076.9/ WO 2023/144163). T.S. received honoraria consulting Primetime Life Sciences, LLC. All other authors declare no competing interests.
